购物车
- 全部删除
- 您的购物车当前为空
GSK180736A 是 Rho 相关卷曲螺旋激酶 1 (ROCK1) 抑制剂,IC50值为 100 nM。它也是选择性的ATP-竞争性 G 蛋白偶联受体激酶 2 抑制剂,IC50值为 0.77 μM,其选择性比其他 GRK 高 100 倍以上。
为众多的药物研发团队赋能,
让新药发现更简单!
GSK180736A 是 Rho 相关卷曲螺旋激酶 1 (ROCK1) 抑制剂,IC50值为 100 nM。它也是选择性的ATP-竞争性 G 蛋白偶联受体激酶 2 抑制剂,IC50值为 0.77 μM,其选择性比其他 GRK 高 100 倍以上。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 253 | 现货 | |
2 mg | ¥ 358 | 现货 | |
5 mg | ¥ 589 | 现货 | |
10 mg | ¥ 849 | 现货 | |
25 mg | ¥ 1,670 | 现货 | |
50 mg | ¥ 2,970 | 现货 | |
100 mg | ¥ 3,820 | 现货 | |
500 mg | ¥ 8,450 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 497 | 现货 |
产品描述 | GSK180736A is an effective and selective GRK2 inhibitor (IC50: 0.77 μM) and >100-fold selectivity over other GRKs. It is a weak inhibitor of PKA (IC50: 30 μM), but highly effective against ROCK1 (IC50: 100 nM). |
靶点活性 | GRK2:0.77 μM, ROCK1:100 nM |
体外活性 | GSK180736A 对 GRK2 表现出 770 nM 的 IC50 值,并且对 GRK5 的抑制效力低 300 倍[2]。它对 PKA 是弱抑制剂,IC50 为 30 μM,但对 ROCK1 具有高度的抑制效果(IC50 = 100 nM)[3]。 |
细胞实验 | Cardiac myocytes are isolated from LV free wall and septum of C57/Bl6 mice. Cells are treated with isoproterenol (0.5 μM) for 2 min for the recording of contraction, with pretreatment of either PBS as vehicle or paroxetine (10 μM), 215022 (0.1, 0.5, 1, 10 μM), 215023 (0.1, 0.5, 1, 10 μM), 224064 (0.1, 0.5, 1, 10 μM), and GSK180736A ( 0.5, 1 μM), for 10 min[1]. |
别名 | GSK180736 |
分子量 | 365.36 |
分子式 | C19H16FN5O2 |
CAS No. | 817194-38-0 |
Smiles | CC1=C(C(NC(=O)N1)c1ccc(F)cc1)C(=O)Nc1ccc2[nH]ncc2c1 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 60 mg/mL (164.22 mM) Ethanol: 3 mg/mL (8.21 mM) | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容